MedTrace Logo

The Clinical Research of Intranasal Dexmedetomidine Used in Plastic Surgery of Children

NCT02222636 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2014-08-21

No results posted yet for this study

Summary

The purpose of this study is to explore the optimal protocol for dexmedetomidine used in children during perioperative period.

Conditions

  • The Efficacy and Safety of Intranasal Dexmedetomidine

Interventions

DRUG

Normal saline,1 milliliter

Normal saline,1 milliliter, 20 minutes before anaesthetic induction

DRUG

Dexmedetomidine 1 μg.kg-1,1 milliliter

Dexmedetomidine 1 μg.kg-1,1 milliliter,20 minutes before anesthesia induction

DRUG

Dexmedetomidine 2μg.kg-1,1 milliliter

Dexmedetomidine 2μg.kg-1,1 milliliter,20 minutes before anesthesia induction

DRUG

Anesthesia induction, 8% sevoflurane

Inhalation induction with 8% sevoflurane

DRUG

Anesthesia maintenance, 2%~3% sevoflurane,fentanyl

2%\~3% sevoflurane,inhalation. fentanyl,2μg.kg-1.min-1,intravenous infusion

Sponsors & Collaborators

  • Xijing Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-08-31
Completion
2015-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02222636 on ClinicalTrials.gov